International Biotechnology Trust PLC Chemo Centryx, Inc. Transaction History

International Biotechnology Trust PLC

$295 Million
Q3 2023

Shares

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 16, 2022	SELL	$15.36 - $27.51 $508,416 - $910,581	-33,100 Reduced 91.69%	3,000 $121 Million
Q4 2021 Feb 15, 2022	SELL	$18.38 - $40.5 $1.07 Million - $2.36 Million	-58,200 Reduced 61.72%	36,100 $1.31 Million
Q3 2021 Nov 12, 2021	BUY	$13.18 - $19.83 $477,116 - $717,845	36,200 Added 62.31%	94,300 $7.13 Million
Q2 2021 Aug 11, 2021	SELL	$9.59 - $50.88 $2.21 Million - $11.7 Million	-230,500 Reduced 79.87%	58,100 $4.04 Million
Q1 2021 May 17, 2021	BUY	$49.53 - $68.4 $1.63 Million - $2.26 Million	33,000 Added 12.91%	288,600 $14.8 Million
Q4 2020 Feb 19, 2021	BUY	$47.25 - $65.16 $11 Million - $15.1 Million	232,000 Added 983.05%	255,600 $15.8 Million
Q3 2020 Dec 01, 2020	SELL	$46.35 - $61.69 $7.79 Million - $10.4 Million	-168,000 Reduced 87.68%	23,600 $1.29 Million
Q2 2020 Jul 14, 2020	BUY	$38.58 - $65.07 $61,728 - $104,111	1,600 Added 0.84%	191,600 $10.5 Million
Q1 2020 May 18, 2020	BUY	$32.73 - $50.78 $6.22 Million - $9.65 Million	190,000 New	190,000 $7.63 Million

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.